Overall rank by patents
#31,386
Across all tracked assignees
USPTO PatentsView assignee record - 8 granted patents across 14 technology areas, active 2015–2019. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C12P (FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE).
The verdict
Direvo holds 8 US patents across 14 technology areas, rank #31,386 of 50,000 tracked assignees.
Direvo Industrial Biotechnology Gmbh has been granted 8 US utility patents between 2015 and 2019, placing Direvo Industrial Biotechnology Gmbh at rank #31,386 across all assignees tracked by PlainPatent. This portfolio spans 14 distinct Cooperative Patent Classification (CPC) subclasses, averaging 10.9 claims per patent with primary concentration in C12P (FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE). As a Foreign Corporation, Direvo Industrial Biotechnology Gmbh is one of the more focused assignees in the PatentsView dataset. By volume, Direvo sits between Digma Medical Ltd. (8 patents, rank #31,382) and Distributed Solar Development, Llc (8 patents, rank #31,390) - the closest US assignees by grant volume. The composite Innovation Score of 27.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 0 grants, compared with 8 in the 2015–2019 window, a -100% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Direvo Industrial Biotechnology Gmbh's 10.9 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 14 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Direvo Industrial Biotechnology Gmbh against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
DIGMA MEDICAL LTD.
8 patents
DIMICRON INC.
8 patents
DINEX A/S
8 patents
DIRAK Dieter Ramsauer Konstruktionselemente GmbH
8 patents
DISINTERMEDIATION SERVICES, INC.
8 patents
DISPERSOL TECHNOLOGIES, LLC
8 patents
DISSING A/S
8 patents
DISTRIBUTED SOLAR DEVELOPMENT, LLC
8 patents
DIREVO Industrial Biotechnology GmbH
8 patents
What this shows Direvo holds 8 patents at rank #31,386, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #31,386 in granted patent volume.
Other assignees with the most granted patents in Direvo's primary technology class.
Direvo's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
27 Top 77% higher than 23% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 12.5% |
| 2017 | 1 | 12.5% |
| 2018 | 3 | 37.5% |
| 2019 | 3 | 37.5% |
Top 14 of 14 technology areas
Overall rank by patents
#31,386
Across all tracked assignees
27.3 out of 100
How to use this portfolio
Direvo's 8 grants land it in the top 77% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.